Conclusion and Implications
This work highlights the crucial role of Cav3.2 channels
in inflammation and related pain and suggests that targeting
Cav3.2 channels with pharmacological agents could be an
attractive and readily evaluable strategy in a clinical trial to relieve
chronic inflammatory pain in affected patients.
Keywords: inflammatory pain, rheumatoid arthritis (RA), T-type
calcium channels.